Aberrant IgG glycosylation correlates with cancer progression and serves as a novel aging-associated factor
New research links immune proteins to cancer and aging processes
This narrative review explores the role of Immunoglobulin G (IgG) in cancer progression and multi-organ aging processes. The authors synthes…
A new look at immune proteins called IgG reveals how they change as we age and play a role in how cancer progresses.
Ivonescimab-containing chemoimmunotherapy can trigger rare ADAMTS13 inhibitor-positive immune thrombotic thrombocytopenic purpura
New Case Highlights Rare Kidney Risk in Lung Cancer Treatment
This case report and literature review describes a patient with stage IVB lung adenocarcinoma who developed iTTP after receiving an ivonesci…
A single case report identifies a rare blood and kidney condition that can occur during specific lung cancer treatments involving ivonescima…
Pharmacokinetic and clinical data inform therapeutic selection for difficult to treat Pseudomonas aeruginosa CNS infections
New strategies help treat drug resistant brain infections
This narrative review evaluates the feasibility of various antimicrobial agents, including ceftolozane-tazobactam, ceftazidime-avibactam, az…
Doctors are finding new ways to treat serious brain infections caused by bacteria that have become hard to kill with standard medicine.
Postoperative food allergen exposure may impede wound healing through inflammatory responses and delayed angiogenesis
Food Allergens May Slow Healing After Malignant Tumor Surgery
This systematic review examines the impact of potential food allergen exposure on wound healing and immune tolerance in patients following m…
Exposure to certain food allergens after surgery for malignant tumors may slow down the healing process by triggering inflammation and delay…
FDA Approves Cellcept (mycophenolate mofetil) for Organ Rejection Prophylaxis
FDA approves Cellcept to prevent organ rejection in transplant patients
The FDA approved Cellcept (mycophenolate mofetil) for prophylaxis of organ rejection in adult and pediatric recipients 3 months and older of…
The FDA has approved Cellcept to help prevent organ rejection in adults and children aged 3 months and older who receive kidney, heart, or l…
FDA Approves Cellcept (mycophenolate mofetil) for Organ Rejection Prophylaxis
FDA approves Cellcept to prevent organ rejection in transplant patients.
The FDA approved Cellcept (mycophenolate mofetil) for prophylaxis of organ rejection in adult and pediatric recipients 3 months and older of…
The FDA has approved Cellcept to help prevent organ rejection in patients who have received a kidney, heart, or liver transplant. It is for …
Depemokimab maintains trough concentrations 90% above EC level with predicted half-life of 47 days
New data supports twice yearly dosing for asthma and sinus disease
This observational analysis of pharmacokinetic and pharmacodynamic data from Phase I and Phase III trials evaluated depemokimab in patients …
A new analysis of trial data shows a specific treatment for asthma and nasal polyps may only need to be given twice a year.
High-dose omega-3 PUFA and EPA significantly reduce risk of asthma and wheezing in children
High dose omega-3 fatty acids may lower asthma risk in children
This meta-analysis of 4156 children evaluated the impact of omega-3 polyunsaturated fatty acids on asthma. Findings indicate that high-dose …
New data suggests that specific high doses of omega-3 fatty acids and EPA could significantly reduce the risk of asthma and wheezing in chil…
Cloud-based intelligent management system improves medication adherence 89.2% vs 58.0% in pediatric asthma
Smart monitoring helps children with asthma manage their symptoms better
This randomized controlled trial of 208 children aged 6 to 12 years found that a cloud-based integrated intelligent management system signif…
A cloud-based management system significantly improved medication habits and lung function for children living with bronchial asthma.
Nanomedicine platforms reshape osteosarcoma tumor microenvironment, showing strong preclinical potential
New delivery methods show promise for treating bone cancer
This mini-review examines nanomedicine delivery systems, including biomimetic, stimuli-responsive, and bone-targeted platforms, for osteosar…
Nanomedicine platforms may help overcome physical and cellular barriers to reshape the environment around osteosarcoma tumors.
Asthma and COPD are associated with significantly increased risk of pertussis infection
Asthma and COPD Patients Face Higher Risk of Pertussis Infection
This meta-analysis of 10 studies involving over 18.6 million participants indicates that patients with asthma or COPD face a higher risk of …
People with asthma or COPD may face a significantly higher risk of contracting pertussis, according to an analysis of over 18 million partic…
FDA Approves Cellcept (mycophenolate mofetil) for Organ Rejection Prophylaxis
FDA approves Cellcept to prevent organ rejection in transplant patients.
The FDA approved Cellcept (mycophenolate mofetil) for prophylaxis of organ rejection in adult and pediatric patients 3 months and older rece…
The FDA has approved Cellcept (mycophenolate mofetil) to help prevent organ rejection in adults and children aged 3 months and older who hav…